Yum Yum Kids is pleased to bring you the very latest updates from around the world on the issue of Bishpenol A or BPA. The latest release dated 17 January is highlighted below:
Bisphenol A (BPA) is an industrial chemical that has been present in many hard plastic bottles and metal-based food and beverage cans since the 1960s.
Studies employing standardized toxicity tests have thus far supported the safety of current low levels of human exposure to BPA. However, on the basis of results from recent studies using novel approaches to test for subtle effects, both the National Toxicology Program at the National Institutes of Health and FDA have some concern about the potential effects of BPA on the brain, behavior, and prostate gland in fetuses, infants, and young children. In cooperation with the National Toxicology Program, FDA’s National Center for Toxicological Research is carrying out in-depth studies to answer key questions and clarify uncertainties about the risks of BPA.
In the interim:
- FDA is taking reasonable steps to reduce human exposure to BPA in the food supply. These steps include:
- supporting the industry’s actions to stop producing BPA-containing baby bottles and infant feeding cups for the U.S. market;
- facilitating the development of alternatives to BPA for the linings of infant formula cans; and
- supporting efforts to replace BPA or minimize BPA levels in other food can linings.
- FDA is supporting a shift to a more robust regulatory framework for oversight of BPA.
- FDA is seeking further public comment and external input on the science surrounding BPA.
- FDA is also supporting recommendations from the Department of Health and Human Services for infant feeding and food preparation to reduce exposure to BPA.
- FDA is not recommending that families change the use of infant formula or foods, as the benefit of a stable source of good nutrition outweighs the potential risk from BPA exposure.
For a full copy of the release please see below:
FDA Releases New Statement on Bisphenol-A (BPA)
FDA today issued a statement on BPA. Attached as a PDF file, and provided below as a link to the FDA website, is the agency’s decision.